Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1981 in asthmatic patients (Sweapea)
NCT01197794Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 2, randomised, double-blind trial of timapiprant in asthma (7 arms), sponsored by AstraZeneca. Primary endpoint: Pre-bronchodilator Forced Expiratory Volume in 1 second at 12 weeks. Started Oct 2010; status: completed.
02
Drugs
timapiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01197794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197794.